President Obama’s signing of the national health reform bill yesterday marks an historic achievement in American history on par with the passage of Social Security and Medicare.  The Patient Protection and Affordable Care Act (summary here) establishes a

It's been 927 days (back of our envelope, anyways) since Senators Charles Grassley and Herb Kohl first introduced the Physician Payments Sunshine Act, a bill that would require drug and device companies to disclose on a public, searchable website the gift

The U.S. House of Representatives passed the most comprehensive health care bill since Medicare last night--a bill that provides health care coverage to 32 million more Americans, ends decades of unjust health insurance practices that discriminate against

I don't watch the show 24, but here at the Hub, I'm getting the idea. Health care reform in real time. The clock running down on the House vote. And for this blogger, not a whole lot of commercial breaks. Here is a summary of the bill, with a little discu

Whether you think we need more evidence that drug prices have become outrageous or not, the following blog describes the theft of an estimated $75 million in prescription drug from an Eli Lilly warehouse this week (posted yesterday on POSTSCRIPT.)  And st

The astonishing theft of $75 million worth of antidepressants and other drugs through the roof of an Eli Lilly distribution warehouse in Connecticut earlier this week is just the latest and most acrobatic incident in a rash of prescription drug theft, and

After a stormy voyage of more than a year, this Monday morning finds the good ship health reform within sight of a final vote. The tentative timetable has a CBO score out today or tomorrow, Rules Committee action on Wednesday and a vote before the end of

(The following blog was posted yesterday on Community Catalyst's Postscript blog. It highlights an exchange between FDA Deputy Commissioner Joshua Sharfstein an Congressman Dingell concerning the need for increased FDA authority and resources to effective

Yesterday, the House Energy and Commerce Subcommittee on Health heard from FDA Deputy Commissioner Joshua Sharfstein on the safety of the drug supply and current agency practices to ensure the safety of marketed drugs. Sharfstein, who has been a strong ad